Medicom Healthcare

What Medicom Healthcare does

Medicom Healthcare Limited is a UK-based specialty pharmaceutical and medical device manufacturer focused exclusively on ophthalmology, founded in 2006 and operating from its UK and Global Head Office in Windsor with a registered office in London (company number 3949112, VAT GB760142461). The company develops, manufactures and commercialises ophthalmic products across five therapeutic classes: Dry Eye, Ocular Hygiene, Infection, Blepharitis and Glaucoma. Its core technical differentiator is preservative-free formulation design that eliminates cytotoxic additives to protect the cornea, supported by MHRA-aligned adverse-event reporting and contracted pharmacovigilance through Red Line Pharmacovigilance Limited. The portfolio spans both pharmaceutical products (regulated medicinal products) and medical device products, unified under a corneal-protection positioning.

Medicom operates a sales-led go-to-market model targeting healthcare professionals — ophthalmologists, optometrists and other eye-care practitioners — who prescribe and recommend its products to patients. Distribution is multi-channel: NHS supplier framework participation (with Carbon Neutral certification, ISO 14068-1, aligned to the NHS Net Zero supplier roadmap), UK and international pharmacy channels, and third-party distribution partnerships with VISUfarma BV in the Netherlands and Aequus Pharmaceuticals in Canada for adverse-event handling and product reach.

The revenue model is commercial product sale of pharmaceuticals and medical devices; pricing is not publicly disclosed and healthcare professionals or patients are directed to sales contacts. Customer segments include healthcare professionals (primary), end-use patients (secondary) and healthcare payers such as the NHS (secondary). The company markets itself as a fast-growing participant in the global ophthalmic market with a robust product pipeline; no funding rounds, management team details, patents, trademarks or revenue figures are publicly disclosed, and ownership appears to remain private and independent.

Name

Medicom Healthcare

Legal name

Medicom Healthcare Limited

Website

https://medicomhealthcare.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

51–100 employees

Short description

Medicom Healthcare is a UK-based specialty pharmaceutical and medical device manufacturer developing preservative-free ophthalmic products across Dry Eye, Ocular Hygiene, Infection, Blepharitis and Glaucoma, serving healthcare professionals, patients and the NHS through pharmacy and distribution channels.

Ownership category

akta.pro rank

Product category

Ophthalmic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Ophthalmology Specialty Pharmaceuticals (HLAIACAK)

akta.pro secondary industry

Ocular Drug Delivery Devices (Eye Droppers/Inserts) (HLAHAIAL)

Keywords

• Ophthalmic pharmaceuticals
• Eye care products
• Ophthalmic medical devices
• Preservative-free formulations
• Dry eye treatments

Headquarters

HQ city

Fareham

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Pharmaceutical Products: Development, manufacturing and commercialisation of ophthalmic pharmaceutical products in therapeutic categories including Dry Eye, Ocular Hygiene, Infection, Blepharitis, and Glaucoma.
2. Medical Devices: Manufacturing and commercialisation of ophthalmic medical device products.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Medicom Healthcare develops, manufactures, and commercialises ophthalmic pharmaceutical and medical device products across five therapeutic classes: Dry Eye, Ocular Hygiene, Infection, Blepharitis, and Glaucoma. The company specialises in preservative-free formulations designed to protect the cornea and serves healthcare professionals and patients in the UK and international markets.

Product overview

Medicom Healthcare operates as an ophthalmic pharmaceutical and medical device company that develops, manufactures, and commercialises products across five therapeutic classes: Dry Eye, Ocular Hygiene, Infection/Blepharitis, and Glaucoma. The company serves healthcare professionals and patients through its unified product portfolio spanning both pharmaceutical and medical device categories, with a focus on eyecare products designed to protect the cornea.

Differentiator

Problem solved

Functional benefit

Products and services

• Dry Eye Products Pharmaceutical and medical device products for the treatment and management of dry eye conditions within Medicom Healthcare's ophthalmic therapeutic portfolio, designed to protect the cornea using preservative-free formulations.
• Ocular Hygiene Products Products designed for ocular surface hygiene and maintenance, forming part of the company's ophthalmic pharmaceutical and medical device portfolio.
• Infection Products Anti-infective ophthalmic pharmaceutical and medical device products for treating eye infections, included in the company's therapeutic product range.
• Blepharitis Products Products targeting blepharitis, an inflammatory condition of the eyelids, within the company's ophthalmic pharmaceutical and medical device portfolio.
• Glaucoma Products Pharmaceutical products for the management and treatment of glaucoma, part of the company's ophthalmic therapeutic offerings.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• Red Line Pharmacovigilance LimitedcoreTechnology or IntegrationPharmacovigilance service provider based in Milton Keynes, UK. Assesses whether information provided may constitute an adverse event relating to Medicom products and reports to relevant authorities as required by law.
• VISUfarma BVcoreChannel Partner/ Reseller/ DistributorNetherlands-based pharmaceutical distributor located at Rembrandt Tower, Amsterdam. Distributes Medicom Healthcare products and assesses adverse events related to distributed products, reporting to relevant authorities.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Alcon: World's largest dedicated ophthalmic company covering pharmaceuticals, devices, and surgical products across Dry Eye, Glaucoma, Infection, and Blepharitis—the primary global incumbent Medicom competes against.
• Bausch + Lomb: Global ophthalmic pharma and devices incumbent with a deep portfolio spanning Dry Eye, Glaucoma, Infection and ocular surface—dominant competitor across most of Medicom's therapeutic classes.

Direct peers

• Santen Pharmaceutical: Japan-headquartered global ophthalmic specialty pharma focused on Dry Eye, Glaucoma, and ocular surface disease—operates in the same five therapeutic categories Medicom targets and competes head-to-head in European tenders.
• Altacor: UK ophthalmic specialty pharmaceutical company with dry eye and ocular surface products—small, UK-based pure-play competitor in the same therapeutic segments and channel as Medicom.
• Alliance Pharmaceuticals: UK specialty pharma with ophthalmic and dermatology products including Dry Eye brands—same UK distribution channels, NHS supplier framework participation, and prescriber targets as Medicom.
• Scope Ophthalmics: UK-based specialty ophthalmic company focused on dry eye, lid hygiene, and ocular surface disease, closely overlapping Medicom's Dry Eye and Ocular Hygiene product lines and UK prescribing audience.
• Théa Pharmaceuticals: European family-owned ophthalmic specialty pharmaceutical company with a broad Dry Eye, Allergy, and Glaucoma portfolio across multiple European markets—most direct geographic and portfolio analogue to Medicom.
• VISUfarma: Netherlands-based ophthalmic pharmaceutical company distributing dry eye, lid hygiene, and nutritional supplement products across Europe; already a Medicom distribution partner, indicating product and channel overlap.

Emerging players

• Nicox: European ophthalmic R&D company focused on preservative-free Glaucoma and Dry Eye therapeutics—directly comparable on the preservative-free formulation thesis and glaucoma focus, though earlier-stage.

Regional players

• Aequus Pharmaceuticals: Canadian specialty pharma with ophthalmic and neurology assets, already a Medicom partner for adverse-event handling—overlapping product categories but primarily North American.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Medicom-Healthcare-Limited-212515382115611
• LinkedInlinkedin.com/company/medicom-healthcare

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medicom Healthcare